Navigation Links
Adams Respiratory Therapeutics and Lipocine Enter into License and Collaboration Agreement
Date:9/19/2007

Adams Seeks to Develop New Prescription Adult Cough Products Using

Lipocine's Proprietary Lip'ral(TM) Technologies

CHESTER, N.J. and SALT LAKE CITY, Sept. 19 /PRNewswire-FirstCall/ -- Adams Respiratory Therapeutics, Inc. (Nasdaq: ARxT) and Lipocine Inc., a privately- held, leading drug delivery company that uses clinically validated proprietary technologies to address key unmet drug delivery and therapeutics needs, today announced that they have entered into a license and collaboration agreement to develop new prescription adult cough products.

Commenting on the agreement, COO Robert D. Casale said, "This collaboration with Lipocine provides Adams with access to an additional proprietary platform technology and fits with our strategy of taking established compounds and adding increased functionality to create patent- protected, value-added products. The products developed through this collaboration could offer doctors a non-narcotic prescribing option to treat cough with an enhanced dosing regimen. In addition, these products will help Adams compete in the $1.1 billion prescription cough and cold market in the United States."

"Given the large and growing size of the respiratory market, and how patients can benefit from enhanced dosage forms and regimens, we are very pleased to partner with Adams, a company highly respected for its commercialization accomplishments," said Dr. Mahesh Patel, president and CEO of Lipocine Inc.

Lip'ral(TM) and Lip'ral(TM)-SSR are clinically proven oral delivery technologies for water insoluble drugs that improve absorption and can be extended to enable controlled release of insoluble drugs and drugs with pH- sensitive solubility. Multiple patents h
'/>"/>

SOURCE Adams Respiratory Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
2. NanoRite Innovation Center opens with small science, big promise
3. UW-Madison to receive $125M for bioenergy research center
4. WARF enters licensing agreements for stem cell products
5. Internet-enabled niche markets take center stage
6. Virent enters agreement with Shell Oil unit to make hydrogen with biomass
7. TomoTherapy opens technical training center
8. Stem cell and regenerative medicine center to aid education and commerce
9. Mega-Metro Center may go beyond Chicago and Wisconsin
10. Software company enters health space with RFID solutions on hold
11. Former Fiserv exec to enter Business Hall of Fame

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...ire-FirstCall/ -- Dendreon Corporation (Nasdaq: D...Administration (FDA) provided written acknowledgem...pplication (BLA) for PROVENGE® (sipuleucel-T)...rescription Drug User Fee Act (PDUFA) date of May ...,s amended BLA. Dendreon is seeking licensure for...
(Date:11/20/2009)...EDO recently announced that Dr. Dominique Hebrault...rocess Analytical Technology (PAT) in Green Chemis...09. , (PRWEB) November 20...al Technology (PAT) in Green Chemistry and Green E...cal Technology (PAT) case studies will be presente...
(Date:11/19/2009)... Nov. 19 Spherix Incorpo...ogy for diabetes therapy, and a provider of techni...pplement, biotechnology and pharmaceutical compani...ted $6.3 million registered direct placement to in...ommon stock and warrants to purchase up to 1,104,3...
(Date:11/19/2009)...ire/ - Aegera Therapeutics Inc. announced today th...e 2B study of AEG35156, a targeted antisense thera...ogy indications. ,, The study, entitled "An Ope...nhibitor of Apoptosis (XIAP) Antisense AEG35156 Gi...darubicin in AML Following Failure of a Single Sta...
Breaking Biology Technology:Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2
...In the late ,90s, a constant parade of start-ups c...relied on "monetizing eyeballs" and revenue sharin...valuation. We all know how that story ended: compa... others - that presented a strong value propositio...relied on other companies for their businesses, mo...
...adison, Wis. - One state initiative aimed at galv...s to be having the desired effect. , ,Several emer...start-up momentum, and attracted the attention of ... to a competition that has attracted hundreds of i...duced by the Wisconsin Technology Council , has b...
...adison, Wis. - When it comes to business developm...e,s universities for their next success story. But...oesn,t take a college degree to get good ideas. , ...tion announced that Ryan Pederson, a senior at No... "Creating Your Own Business - Youth Award Contest...
Other Biology Technology:Searching for revenue streams 2Searching for revenue streams 3Winners of past business plan contests secure funding, credibility 2Winners of past business plan contests secure funding, credibility 3Winners of past business plan contests secure funding, credibility 4High schooler's concept wins Eau Claire business contest 2
(Date:11/20/2009)...h Grafton, Mass., November 19, 2009 The estimated...stry may be at risk of developing respiratory symp...ding to a questionnaire study undertaken earlier t...mmings School of Veterinary Medicine. , The stud...workersfound that 50 percent of individuals workin...
(Date:11/20/2009)...s release is available in German . , In the...Investigation , Dr. Stefanie Eyerich and Dr. Kilia...rial College London and Istituto Dermopatico dell,...iscovery. It represents a milestone on the way to ...skin diseases such as psoriasis and allergic react...
(Date:11/20/2009)...PAIGN, Ill. In a new study, researchers report th...rs can have a helpful, or harmful, effect on the h...he study, which appears in the journal Circulatio...both the alpha- and beta-receptors on the heart mu...hile those that target only the beta-receptors can...
Breaking Biology News(10 mins):Barn personnel experience higher-than-average rates of respiratory symptoms 2Discovery of new type of immune cells regulating inflammation in chronic diseases 2Carvedilol shown to have unique characteristics among beta blockers 2In search of wildlife friendly biofuels 10231 1In search of wildlife friendly biofuels 10231 2In search of wildlife friendly biofuels 10231 3Energy autonomous sensors for aircraft 14324 1Energy autonomous sensors for aircraft 14324 2Actress Soleil Moon Frye Cant Be Punkd 3B NFL Star Terrell Owens Upset in Final Minutes of Alzheimers Association Contest 58724 1Actress Soleil Moon Frye Cant Be Punkd 3B NFL Star Terrell Owens Upset in Final Minutes of Alzheimers Association Contest 58724 2
...earchers have discovered a link between a gene bel...flushes cholesterol from the body. , The finding...e risk of diseases associated with high cholestero...d Alzheimer,s disease. , The study focused on a g...ents cholesterol buildup by activating a cellular ...
...ality today, but how can we find out about the fut...l record of the Earths climate for several hundred... different epochs that can be taken to the lab for...icecaps of the Arctic and Antarctic regions, and a...ole in deciphering it. , Professor Thomas Stocker...
...e U.S. Department of Energys Office of Science tod... 2003 publication, Facilities for the Future of Sc...y has made significant progress in deploying the s...ed States needs to capture world scientific leader...the Departments missions. , When it was published...
Other Biology News:MIT links gene to cholesterol 2European lead in reading past climates from ice cores 2European lead in reading past climates from ice cores 3DOE publishes update of plan: 'Facilities for the Future of Science: A 20-Year Outlook' 2DOE publishes update of plan: 'Facilities for the Future of Science: A 20-Year Outlook' 3DOE publishes update of plan: 'Facilities for the Future of Science: A 20-Year Outlook' 4DOE publishes update of plan: 'Facilities for the Future of Science: A 20-Year Outlook' 5
Rhesus Serum from Innovative Research
Anti-Myelin Basic Protein (MBP), aa 129-138 Monoclonal Antibody, Unconjugated, Clone clone 1 from CHEMICON
...Number: NP_001912.1 MW: 20016 Description: FUNCT...late synthetase. CATALYTIC ACTIVITY: dCMP + H 2 O ...Belongs to the Diseases: Benign Tumor; Leukemia; E... Myelogenous Leukemia; Pregnancy; Herpesviruses; A...
...ased on the methodology of Heukeshoven and Dernick...nds in most gel electrophoresis systems.Silver Sta...le and sensitive staining of proteins in polyacryl...n technique detects most proteins in the nanogram ...
Biology Products: